Published in J Med Chem on August 09, 2007
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
Bile acids: regulation of synthesis. J Lipid Res (2009) 4.31
Retracted Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology (2013) 2.16
The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology (2011) 1.71
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69
Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev (2014) 1.58
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J Am Soc Nephrol (2015) 1.47
Bile acid metabolism and signaling. Compr Physiol (2013) 1.42
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One (2011) 1.11
The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis (2011) 0.99
Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway. Immunology (2012) 0.88
Probing the Binding Site of Bile Acids in TGR5. ACS Med Chem Lett (2013) 0.86
Proteomics for the discovery of nuclear bile acid receptor FXR targets. Biochim Biophys Acta (2011) 0.85
The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway. Front Pharmacol (2015) 0.83
Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor. J Lipid Res (2009) 0.81
Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B (2015) 0.81
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists. Sci Rep (2016) 0.80
Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands. Sci Rep (2016) 0.78
Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators. ACS Med Chem Lett (2012) 0.78
Pharmacology and physiology of gastrointestinal enteroendocrine cells. Pharmacol Res Perspect (2015) 0.75
TGR5, Not Only a Metabolic Regulator. Front Physiol (2016) 0.75
Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition. JPEN J Parenter Enteral Nutr (2016) 0.75
Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology. Children (Basel) (2015) 0.75
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab (2008) 5.44
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65
Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov (2008) 4.43
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab (2008) 4.36
SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31
Mitonuclear protein imbalance as a conserved longevity mechanism. Nature (2013) 4.18
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature (2012) 4.15
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell (2013) 3.50
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48
Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab (2006) 3.22
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab (2012) 3.18
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol (2004) 3.04
Endocrine functions of bile acids. EMBO J (2006) 3.03
Nuclear receptors and the control of metabolism. Annu Rev Physiol (2002) 3.00
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr (2011) 2.98
NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell (2011) 2.75
E2Fs regulate adipocyte differentiation. Dev Cell (2002) 2.71
Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med (2007) 2.64
The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell (2002) 2.61
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol (2012) 2.58
Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol (2007) 2.40
Sirtuin functions in health and disease. Mol Endocrinol (2007) 2.38
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell (2004) 2.31
Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell (2011) 2.26
LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol (2004) 2.24
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med (2005) 2.06
mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A (2009) 2.05
The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood (2010) 2.05
Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab (2010) 2.04
Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev (2004) 2.04
The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ Health Perspect (2010) 1.98
AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci (2010) 1.95
The metabolic footprint of aging in mice. Sci Rep (2011) 1.93
Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab (2009) 1.89
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci U S A (2003) 1.89
Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol (2007) 1.89
PPAR(gamma) and glucose homeostasis. Annu Rev Nutr (2002) 1.86
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85
Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem (2002) 1.85
SRT1720 improves survival and healthspan of obese mice. Sci Rep (2011) 1.81
The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc Natl Acad Sci U S A (2008) 1.80
Metabolic networks of longevity. Cell (2010) 1.79
Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics (2008) 1.76
Target flexibility: an emerging consideration in drug discovery and design. J Med Chem (2008) 1.74
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69
Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol (2004) 1.69
Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev (2012) 1.64
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem (2011) 1.62
The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci (2009) 1.62
PPARgamma in human and mouse physiology. Biochim Biophys Acta (2007) 1.58
LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J Clin Invest (2012) 1.58
Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell (2007) 1.58
Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One (2012) 1.58
Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol (2008) 1.57
Mouse functional genomics requires standardization of mouse handling and housing conditions. Mamm Genome (2004) 1.56
Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/- )mice. J Clin Invest (2004) 1.55